logo
Sign in

INNFOCUS, INC.

MIAMI, FL · Founded 2011 · UNCERTAIN · Still private

Professional hotel photography services and visual content creation

Claim this profile

Follows are private to you and power your alerts

Updated · innfocus.co

Sector
UNCERTAIN
Headquarters
MIAMI, FL
Founded
2011
Latest Form D
$32.8M, Oct 2015
Total capital
$48.6M
Federal grants
$270K
2 awards · 2008–2009
2.0× sector median 1 award
Private capital raised
$48.3M
3 Form D · last Oct 2015
133 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
15
25 pending · first 2015

Capital timeline

20082009201020112012201320142015FEDERAL ↑EQUITY ↓Cumulative $48.6M$107K$163K1st Form D$2M2nd Form D$13.5M3rd Form D$32.8M
2008201020122014FEDERAL ↑EQUITY ↓Cumulative $48.6M$107K$163K1st Form D$2M2nd Form D$13.5M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$32.8M
  • Private capital raisedForm D · SEC · 2nd filing$13.5M
  • Private capital raisedForm D · SEC · 1st filing$2M
  • Federal grantHealth and Human S · Phase I · Development of Extraocular Muscle Prosthesis for Paralytic Strabismus$163K
  • Federal grantHealth and Human S · Phase I · Development of MIDI-Ray Implant for Glaucoma$107K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

39months

from INNFOCUS, INC.’s first federal award to its first private round.

First federal award · Apr 2008
Health and Human S · $107K
First Form D · Jun 2011
$2M · 1st Form D
Awards before first raise
2 awards

An association in public records, not a cause or a prediction.

Founders and team

Researcher links verified by same-company patents and grants
  • Leonard PinchukResearcherExecutive Officer, DirectorLinked by 8 patents · $107K in grants as PI
  • Cheryl F. JackmanExecutive OfficerNamed in SEC Form D filings
  • Christian W. MazzolaDirectorNamed in SEC Form D filings
  • C. Russell Trenary, IIIExecutive Officer, DirectorNamed in SEC Form D filings
  • Diane F. PinchukExecutive OfficerNamed in SEC Form D filings
  • John W. Sheets, Jr.DirectorNamed in SEC Form D filings
Show all 8 people
  • Leonard Pinchuk, Ph.D.Executive Officer, DirectorNamed in SEC Form D filings
  • Scott F. HalstedDirectorNamed in SEC Form D filings

What it has protected

USPTO · 15 granted of 40
Show all 40 patent records
  • Systems, Methods, And Apparatus For Treatment Of GlaucomaSep 8, 2026 · US 12,728,035Granted
  • Glaucoma Device InserterApr 1, 2025 · US 12,263,123Granted
  • Ocular ImplantJun 18, 2024 · US 12,011,391Granted
  • Device for Treating GlaucomaAug 8, 2023 · US 11,717,441Granted
  • Implantable Drug Delivery Device With A Self-sealing Reservoir For Treating Ocular DiseasesJun 15, 2023 · Application 17923893Pending
  • Tool(s) for Inserting a Glaucoma ShuntJun 6, 2023 · US 11,666,360Granted
  • Systems, Methods, And Apparatus For Treatment Of GlaucomaFeb 16, 2023 · Application 17977830Pending
  • Systems, Methods, and Apparatus for Treatment of GlaucomaDec 6, 2022 · US 11,517,476Granted
  • Non-degrading Swellable Polymers As Materials For Biomedical DevicesSep 22, 2022 · Application 17616042Pending
  • Glaucoma Device Delivery System and Trans-Conjunctival Method of DeliveryMay 24, 2022 · US 11,337,856Granted
  • Device for Treating GlaucomaSep 15, 2020 · US 10,772,762Granted
  • Device for Treating GlaucomaAug 4, 2020 · US 10,729,583Granted
  • Device for Treating GlaucomaMar 24, 2020 · US 10,596,036Granted
  • Glaucoma Device Delivery System and Trans-Conjunctival Method of DeliveryMar 5, 2019 · US 10,219,943Granted
  • Methods, Systems And Devices For Treating GlaucomaJul 3, 2018 · US 10,010,450Granted
  • Method, Surgical Kit and Device for Treating GlaucomaFeb 13, 2018 · US 9,889,042Granted
  • Inserter for Tubular Medical Implant DevicesMay 16, 2017 · US 9,649,223Granted
  • Methods, Systems and Devices for Treating GlaucomaJun 2, 2015 · US 9,044,301Granted
  • Glaucoma Implant DeviceApplication PCTUS2007077748Pending
  • Apparatus, Methods And Devices For Treatment Of Ocular DisordersApplication PCTUS2007077757Pending
  • Ocular ImplantApplication PCTUS2006061477Pending
  • Elastomeric Polymer Filament Cosmetic ImplantApplication PCTUS2005045120Pending
  • Improved Glaucoma Implant DeviceApplication PCTUS2004040661Pending
  • Glaucoma Drainage Device With Expandable AnchorApplication 19165919Pending
  • Improved Ocular LensApplication PCTUS2004040447Pending
  • Glaucoma Drainage Device With Expandable AnchorApplication PCTUS2024017130Pending
  • Glaucoma Drainage Device With Expandable AnchorApplication 63454006Pending
  • Implantable Drug Delivery Device With A Self-sealing Reservoir For Treating Ocular DiseasesApplication PCTUS2021017412Pending
  • Non-degrading Swellable Polymers As Materials For Biomedical DevicesApplication PCTUS2020035688Pending
  • Ocular ImplantApplication 62982444Pending
  • Glaucoma Device InserterApplication PCTUS2020018940Pending
  • Drug Delivery System with a Self-Sealing Reservoir for Treating Ocular DiseasesApplication 62976543Pending
  • Non-degrading Swellable Polymers As Materials For Biomedical DevicesApplication 62856447Pending
  • Glaucoma Device InserterApplication 62811045Pending
  • Systems, Methods, And Apparatus For Treatment Of GlaucomaApplication PCTUS2018034301Pending
  • Tool(s) For Inserting A Glaucoma ShuntApplication PCTUS2017048431Pending
  • Systems, Methods, and Apparatus for Treatment of GlaucomaApplication 62518944Pending
  • Glaucoma Device Delivery System And Trans-conjunctival Method Of DeliveryApplication PCTUS2016039275Pending
  • Glaucoma Treatment Device, Assembly, And Method Of UseApplication 62263786Pending
  • Glaucoma Device Delivery System and Trans-Conjunctival Method of DeliveryApplication 62185347Pending

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .